Company profilePharmaceutical#93 of 1,318 in Pakistan2 DRAP alerts

MEDICRAFT PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 174 brands · 158 molecules

Ranked #42 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

174 registered products 44 pharmaceutical brands 158 distinct molecules 2 DRAP alerts

Company overview

174
registered products
44
pharmaceutical brands
158
distinct molecules
12
therapeutic classes
2
DRAP alerts

MEDICRAFT PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 174 product registrations across 158 distinct molecules. It is the 93rd largest registrant in Pakistan by product count, and ranks 42nd of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Antianemic, Iron & All Combination. DRAP has issued 2 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by MEDICRAFT

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20251

Top molecules by brand count

Nutritional Supplement / Multivitamin38 brands
Diclofenac5 brands
Pyridoxine5 brands
Paracetamol5 brands
Folic Acid4 brands
Lumefantrine3 brands
Artemether3 brands
Thiamine3 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 6Antianemic, Iron & All Combination · 3Quinolone Antibacterials · 2Angiotensin-Ii Antagonists, Combinations · 2Antianemic, Iron Preparations · 2Other Beta-Lactam, Cephalosporins & Penems · 2Gonadotropins And Other Ovulation Stimulants · 1Antiepileptics · 1Drugs For Constipation · 1Antimycotics Systemic Use · 1Cardiac Therapy · 1Vitamin A, D & Combinations · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official4 products · Rs 249.79 – Rs 361.02
DVAGO1 products · Rs 124.5 – Rs 124.5
Median across source: Rs 307.94

Regulatory record

2 alerts in the DRAP feed we track.

105. Recall Alert – Drug Products for Human Use Declared Substandard
2025-10-30
Recall Alert: Drug Product; Zolan 200mg/5ml Suspension (Batch # L-083) by Swat Pharmaceuti
2023-11-10

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 133 molecules not in this portfolio
AcyclovirAcyclovir SodiumAlfacalcidolAmlodipineAmoxicillinAmoxycillin
SIZA INTERNATIONAL (PVT) LTD. holds 85 molecules not in this portfolio
AcyclovirAlbendazoleAlbuterolAllopurinolAllopurinol TabAmikacin
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 156 molecules not in this portfolio
AlbuterolAmikacinAminophyllineAmlodipineAmlodipine BaseAmmonium Chloride

Get the full profile for MEDICRAFT

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.